MCQ Book Questions

Q51780. Inosine monophophate is an intermediate during the de novo synthesis of

Q51781. Xanthosine monophosphate is an intermediate during de novo synthesis of

Q51782. In the pathway of de novo synthesis of purine nucleotides, all the following are allosteric enzymes except

Q51783. All of the following enzymes are unique to purine nucleotide synthesis except

Q51784. PRPP synthetase is allosterically inhibited by

Q51785. An allosteric inhibitor of PRPP glutamyl amido transferase is

Q51786. An allosteric inhibitor of adenylosuccinate synthetase is

Q51787. An allosteric inhibitor of IMP dehydroge- nase is

Q51788. GMP is an allosteric inhibitor of all the following except

Q51789. AMP is an allosteric inhibitor of

Q51790. The first reaction unique to purine nucleo- tide synthesis is catalysed by

Q51791. Free purine bases which can be salvaged are

Q51792. The enzyme required for salvage of free purine bases is

Q51793. Deoxycytidine kinase can salvage

Q51794. Adenosine kinase can salvage

Q51795. Salvage of purine bases is regulated by

Q51796. The available PRPP is used preferentially for

Q51797. The end product of purine catabolism in man is

Q51798. The enzyme common to catabolism of all the purines is

Q51799. Uric acid is the end product of purine as well as protein catabolism in